Get complete Patent Opposition Report for Von Seebach

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Von Seebach

Explore patent oppositions filed by Von Seebach against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3453387Dosage Regimen For A S1P Receptor AgonistNOVARTISMar 3, 2021
EP3409274Dosage Regimen For A S1P Receptor AgonistNOVARTISAug 18, 2020
EP3246021Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDAug 6, 2020